Skip to content

Pulse Biosciences, Inc. PLSE Change in Other Assets

Change in Other Assets at other companies

Merit Medical Systems logo
Merit Medical SystemsMMSI
-$1.89M+7.6%
ITG
Integer HoldingsITGR
$2.84M+143%
LivaNova logo
LivaNovaLIVN
$4.2M+165%
Capricor Therapeutics logo
Capricor TherapeuticsCAPR
-$979.78K-1,666%
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
-$6.28M-239%
IPG Photonics logo
IPG PhotonicsIPGP
$11.43M+87.8%

Other financials

Income statement

See full
Revenue$401.0K
Gross profit$31.0K
Operating income-$19.2M-6.1%
Net income-$18.6M-10.6%
EPS (diluted)-$0.49-2.1%

Balance sheet

See full
Cash & equivalents$68.3M-42.7%
Total debt$7.2M-16.6%
Total equity$66.3M-44.0%
Total assets$81.6M-38.8%

Cash flow

See full
Operating cash flow-$14.6M-7.9%
CapEx$33.0K-26.7%
Free cash flow-$14.6M-7.8%

Valuation

See full
Market cap$1.77B+38.4%

Profitability

See full
Gross margin-4,067.5%
Operating margin-10,392.1%
Net margin-9,929%
FCF margin-7,390%

Returns & leverage

See full
Return on equity-80.7%+3.1pp
Debt / equity0.1×0.0×
Current ratio7.3×-8.3×

Where this comes from

Reported directly by Pulse Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherNoncurrentAssets.

The official record: Pulse Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pulse Biosciences, Inc.'s change in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pulse Biosciences, Inc.'s change in other assets?
Pulse Biosciences, Inc. (PLSE) reported change in other assets of -$3K in Q1 2026.
How has Pulse Biosciences, Inc.'s change in other assets changed year-over-year?
Pulse Biosciences, Inc.'s change in other assets decreased by 400.0% year-over-year, from $1K to -$3K.
What does change in other assets mean?
Change in miscellaneous assets affecting operating cash flow.